11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:26 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:27 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:26 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:34 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
| Form SC 13D | |
08/16/2024
3:35 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:25 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:51 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
1:22 PM | BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024
3:21 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2024
11:15 PM | Citius Pharmaceuticals (Filer)
| Form EFFECT | |
02/23/2024
3:23 PM | Citius Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/23/2024
3:18 PM | Citius Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
7:45 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:18 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
| Form SC 13G | |
01/23/2024
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CTXR Stock Alerts